VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,795,000 | +121.7% | 163,444 | +52.0% | 0.01% | +100.0% |
| Q1 2018 | $1,712,000 | -85.3% | 107,543 | -80.8% | 0.00% | -82.4% |
| Q4 2017 | $11,623,000 | +41.6% | 559,173 | -2.4% | 0.02% | +30.8% |
| Q3 2017 | $8,209,000 | -64.6% | 572,926 | -57.3% | 0.01% | -69.0% |
| Q2 2017 | $23,208,000 | +263.5% | 1,341,377 | +131.7% | 0.04% | +223.1% |
| Q1 2017 | $6,384,000 | +9.1% | 578,818 | +43.4% | 0.01% | -7.1% |
| Q4 2016 | $5,854,000 | -27.6% | 403,667 | +23.5% | 0.01% | -30.0% |
| Q3 2016 | $8,081,000 | +21.4% | 326,736 | -1.2% | 0.02% | +11.1% |
| Q2 2016 | $6,658,000 | +45.2% | 330,565 | +90.4% | 0.02% | +38.5% |
| Q1 2016 | $4,584,000 | -81.5% | 173,584 | -28.6% | 0.01% | -78.0% |
| Q4 2015 | $24,720,000 | -47.2% | 243,222 | -7.3% | 0.06% | -50.0% |
| Q3 2015 | $46,797,000 | +44.7% | 262,348 | +80.3% | 0.12% | +78.8% |
| Q2 2015 | $32,347,000 | +20.7% | 145,504 | +7.7% | 0.07% | +26.9% |
| Q1 2015 | $26,793,000 | +27.3% | 135,051 | -8.2% | 0.05% | +18.2% |
| Q4 2014 | $21,054,000 | +10.9% | 147,054 | +1.5% | 0.04% | +12.8% |
| Q3 2014 | $18,988,000 | +73.2% | 144,895 | +68.4% | 0.04% | +62.5% |
| Q2 2014 | $10,960,000 | +4.2% | 86,018 | +6.3% | 0.02% | -4.0% |
| Q1 2014 | $10,514,000 | +23.2% | 80,944 | +11.2% | 0.02% | +13.6% |
| Q4 2013 | $8,536,000 | +1.9% | 72,793 | -9.2% | 0.02% | -4.3% |
| Q3 2013 | $8,374,000 | +46.1% | 80,210 | +20.8% | 0.02% | +35.3% |
| Q2 2013 | $5,732,000 | +120.8% | 66,372 | +92.0% | 0.02% | +88.9% |
| Q1 2013 | $2,596,000 | +29.2% | 34,574 | +2.7% | 0.01% | +12.5% |
| Q4 2012 | $2,009,000 | -27.9% | 33,669 | -33.1% | 0.01% | -27.3% |
| Q3 2012 | $2,786,000 | +24.5% | 50,311 | +0.3% | 0.01% | +10.0% |
| Q2 2012 | $2,238,000 | -59.1% | 50,155 | -50.7% | 0.01% | -58.3% |
| Q1 2012 | $5,471,000 | – | 101,831 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |